1. Home
  2. SAMG vs SGMO Comparison

SAMG vs SGMO Comparison

Compare SAMG & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$15.23

Market Cap

125.5M

Sector

Finance

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.47

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
SGMO
Founded
2002
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
125.5M
141.2M
IPO Year
2012
2000

Fundamental Metrics

Financial Performance
Metric
SAMG
SGMO
Price
$15.23
$0.47
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
29.2K
7.7M
Earning Date
01-01-0001
05-11-2026
Dividend Yield
5.54%
N/A
EPS Growth
N/A
66.89
EPS
0.55
N/A
Revenue
$91,358,000.00
$36,567,000.00
Revenue This Year
$3.37
$4.79
Revenue Next Year
$10.62
N/A
P/E Ratio
$27.78
N/A
Revenue Growth
N/A
88.60
52 Week Low
$13.23
$0.35
52 Week High
$18.60
$1.06

Technical Indicators

Market Signals
Indicator
SAMG
SGMO
Relative Strength Index (RSI) 53.67 48.66
Support Level $14.74 $0.35
Resistance Level $15.41 $0.56
Average True Range (ATR) 0.33 0.03
MACD 0.05 0.00
Stochastic Oscillator 78.99 63.33

Price Performance

Historical Comparison
SAMG
SGMO

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: